» Articles » PMID: 32330356

Earliest Cases of Coronavirus Disease 2019 (COVID-19) Identified in Solid Organ Transplant Recipients in the United States

Overview
Journal Am J Transplant
Publisher Elsevier
Specialty General Surgery
Date 2020 Apr 25
PMID 32330356
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

With the rapidly expanding pandemic of SARS-CoV-2, there is concern that solid organ transplant recipients will be particularly vulnerable to infection and may experience a more severe clinical course. We report four cases of COVID-19 in solid organ transplant recipients including recipients of kidney, liver, lung, and heart transplants. We describe each patient's medical history including transplantation history, their clinical presentation and workup, and their course from diagnosis to either hospital discharge or to improvement in symptoms. These reports demonstrate a range of symptoms, clinical severity, and disease course in solid organ transplant recipients with COVID-19, including two hospitalized patients and two patients managed entirely in the outpatient setting.

Citing Articles

Impaired immune responses and prolonged viral replication in lung allograft recipients infected with SARS-CoV-2 in the early phase after transplantation.

Glueck O, Liang X, Badell I, Wratil P, Graf A, Krebs S Infection. 2023; 52(3):847-855.

PMID: 37922037 PMC: 11143031. DOI: 10.1007/s15010-023-02116-6.


Immunogenicity of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV; Sinopharm) and Short-Term Clinical Outcomes in Vaccinated Solid Organ Transplant Recipients: A Prospective Cohort Study.

Shafiekhani M, Mirjalili M, Gholami S, Vatankhah P, Roozbeh J, Mehrdad G Adv Exp Med Biol. 2023; 1412:357-374.

PMID: 37378777 DOI: 10.1007/978-3-031-28012-2_19.


Kidney transplant after a COVID-19.

Pascual J Nefrologia (Engl Ed). 2022; 41(2):91-94.

PMID: 36166213 PMC: 8162902. DOI: 10.1016/j.nefroe.2021.05.004.


An update from the Canadian Association for the Study of the Liver on the management of liver disease during the COVID-19 pandemic.

Brahmania M, Congly S, Jayakumar S, Coffin C, Burak K, Feld J Can Liver J. 2022; 3(4):309-321.

PMID: 35990512 PMC: 9202743. DOI: 10.3138/canlivj-2020-0013.


COVID-19 Pandemic Impact on Liver Donation in the Largest Brazilian Transplantation Center.

Fortunato A, Pinheiro R, Fernandes M, Nacif L, Macedo Arantes R, Rocha-Santos V Transplant Proc. 2022; 54(5):1212-1214.

PMID: 35811150 PMC: 9021359. DOI: 10.1016/j.transproceed.2022.03.045.


References
1.
Huang J, Zheng K, George J, Gao H, Wei R, Yan H . Fatal outcome in a liver transplant recipient with COVID-19. Am J Transplant. 2020; 20(7):1907-1910. PMC: 7262021. DOI: 10.1111/ajt.15909. View

2.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

3.
Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P . In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020; 71(15):732-739. PMC: 7108130. DOI: 10.1093/cid/ciaa237. View

4.
Gandolfini I, Delsante M, Fiaccadori E, Zaza G, Manenti L, Antoni A . COVID-19 in kidney transplant recipients. Am J Transplant. 2020; 20(7):1941-1943. PMC: 7228396. DOI: 10.1111/ajt.15891. View

5.
Lai C, Shih T, Ko W, Tang H, Hsueh P . Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020; 55(3):105924. PMC: 7127800. DOI: 10.1016/j.ijantimicag.2020.105924. View